KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today
Source: finanznachrichten.de